Functional analysis of atypical mutations in exons 13 and 15 of JAK2 gene in myeloproliferative neoplasms

被引：1
|
作者：
Luo, Ming [1 ]
Tian, Tingting [1 ]
Zhang, Yaofang [1 ]
Zhang, Xialin [1 ]
Xie, Juan [1 ]
Xu, Jing [1 ]
Ren, Weixiao [1 ]
Tian, Chuchu [1 ]
Wang, Jiaxuan [1 ]
Tan, Yanhong [1 ]
Wang, Hongwei [1 ]
Chen, Xiuhua [1 ]
机构：
[1] Shanxi Med Univ, Hosp 2, Inst Hematol, 382 Wuyi Rd, Taiyuan 030001, Peoples R China
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2021年 / 43卷 / 03期
基金：
中国国家自然科学基金;
关键词：
atypical mutation; JAK2; myeloproliferative neoplasms; PSEUDOKINASE DOMAIN;
D O I：
10.1111/ijlh.13398
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E110 / E113
页数：4
相关论文
共 50 条
  • [31] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients
    Mayumi Tanaka
    Toshiaki Yujiri
    Shunsuke Ito
    Naoko Okayama
    Toru Takahashi
    Kenji Shinohara
    Yoichi Azuno
    Ryouhei Nawata
    Yuji Hinoda
    Yukio Tanizawa
    International Journal of Hematology, 2013, 97 : 409 - 413
  • [32] The JAK2 46/1 haplotype is a risk factor for myeloproliferative neoplasms in Chinese patients
    Zhang, Xinju
    Hu, Tingting
    Wu, Zhiyuan
    Kang, Zhihua
    Liu, Weiwei
    Guan, Ming
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (05) : 611 - 616
  • [33] TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients
    Matsuguma, Masafumi
    Yujiri, Toshiaki
    Yamamoto, Kaoru
    Kajimura, Yasuko
    Tokunaga, Yoshihiro
    Tanaka, Mayumi
    Tanaka, Yoshinori
    Nakamura, Yukinori
    Tanizawa, Yukio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (06) : 690 - 698
  • [34] The JAK2 46/1 haplotype is a risk factor for myeloproliferative neoplasms in Chinese patients
    Xinju Zhang
    Tingting Hu
    Zhiyuan Wu
    Zhihua Kang
    Weiwei Liu
    Ming Guan
    International Journal of Hematology, 2012, 96 : 611 - 616
  • [35] JAK2 allele burden in the myeloproliferative neoplasms: effects on phenotype, prognosis and change with treatment
    Vannucchi, Alessandro M.
    Pieri, Lisa
    Guglielmelli, Paola
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2011, 2 (01) : 21 - 32
  • [36] The roles of JAK2 in DNA damage and repair in the myeloproliferative neoplasms: Opportunities for targeted therapy
    Karantanos, Theodoros
    Moliterno, Alison R.
    BLOOD REVIEWS, 2018, 32 (05) : 426 - 432
  • [37] TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients
    Masafumi Matsuguma
    Toshiaki Yujiri
    Kaoru Yamamoto
    Yasuko Kajimura
    Yoshihiro Tokunaga
    Mayumi Tanaka
    Yoshinori Tanaka
    Yukinori Nakamura
    Yukio Tanizawa
    International Journal of Hematology, 2019, 110 : 690 - 698
  • [38] Case series: patients with JAK2 positive myeloproliferative neoplasms associated with thrombotic events
    Combariza, J. F.
    Olaya, V
    Galvez, K.
    Ballesteros, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 88 - 88
  • [39] JAK2 Variant Signaling: Genetic, Hematologic and Immune Implication in Chronic Myeloproliferative Neoplasms
    Torres, Dania G.
    Paes, Jhemerson
    da Costa, Allyson G.
    Malheiro, Adriana
    Silva, George V.
    Mourao, Lucivana P. de Souza
    Tarrago, Andrea M.
    BIOMOLECULES, 2022, 12 (02)
  • [40] Frequency and Molecular Characteristics of Calreticulin Gene (CALR) Mutations in Patients with JAK2-Negative Myeloproliferative Neoplasms
    Wojtaszewska, Marzena
    Iwola, Malgorzata
    Lewandowski, Krzysztof
    ACTA HAEMATOLOGICA, 2015, 133 (02) : 193 - 198
12345